NIPER world conference

Tribune News Service

Updated At : 01:51 PM Nov 13, 2022 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Mohali, November 12

Third day of an international conference on recent trends and future opportunities in pharmaceuticals, NIPER-Pharmacon-2022, saw sessions on “Therapeutic approaches for CNS diseases”, “Startups: Challenges and opportunities”, “Pharmacogenomics and precision medicine”, and “Challenges and opportunities in drug discovery and development” at the National Institute of

Pharmaceutical Education and Research (NIPER), here today.

Dr Ajit Dua, from Punjab Biotechnology Incubator here, also spoke about the “Use of isotope fingerprints in authentication of natural products”. There was a valedictory function at NIPER Convention Centre.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles